Literature DB >> 9440349

Synthesis of certain 5-substituted 2-thiohydantoin derivatives as potential cytotoxic and antiviral agents.

A I Khodair1, H I el-Subbagh, A A el-Emam.   

Abstract

A convenient route is reported for the synthesis of certain series of 2-thiohydantoins carrying various heterocyclic substituents such as 5-bromothienylidene 3a,b, 5-(2-carboxyphenylthio)-2-thienylidene 4a,b and 4H-thieno[2,3-b][1]benzothiopyran-4-one 5a,b. Glycosylation of these thiohydantoins afforded the S-glycosyl derivatives 10a-d. The synthesized compounds were tested for their activity against HIV-1 virus and as antitumor agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440349

Source DB:  PubMed          Journal:  Boll Chim Farm        ISSN: 0006-6648


  5 in total

1.  A simple synthesis of 2-thiohydantoins.

Authors:  Zerong Daniel Wang; Samia O Sheikh; Yulu Zhang
Journal:  Molecules       Date:  2006-10-02       Impact factor: 4.411

2.  (3E,5E)-1-Acryloyl-3,5-bis-(2-chloro-benzyl-idene)piperidin-4-one.

Authors:  Alireza Basiri; Vikneswaran Murugaiyah; Hasnah Osman; Madhukar Hemamalini; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-04-29

3.  (3E,5E)-3,5-Bis(naphthalen-1-yl-methyl-idene)piperidin-4-one.

Authors:  Yalda Kia; Hasnah Osman; Vikneswaran Murugaiyah; Suhana Arshad; Ibrahim Abdul Razak
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-24

4.  Microwave assisted synthesis of novel functionalized hydantoin derivatives and their conversion to 5-(Z) arylidene-4H-imidazoles.

Authors:  Sukanta Kamila; Haribabu Ankati; Edward R Biehl
Journal:  Molecules       Date:  2011-06-29       Impact factor: 4.411

5.  Copper coordination compounds with (5Z,5Z')-2,2'-(alkane-α,ω-diyldiselenyl)-bis-5-(2-pyridylmethylene)-3,5-dihydro-4H-imidazol-4-ones. Comparison with sulfur analogue.

Authors:  Alexander V Finko; Anatolii I Sokolov; Dmitry A Guk; Victor A Tafeenko; Anna A Moiseeva; Dmitry A Skvortsov; Andrei A Stomakhin; Andrei A Beloglazkin; Roman S Borisov; Vladimir I Pergushov; Mikhail Ya Melnikov; Nikolay V Zyk; Alexander G Majouga; Elena K Beloglazkina
Journal:  RSC Adv       Date:  2022-03-02       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.